# Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda

> **NCT00339456** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 155 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** HAART

## Key facts

- **NCT ID:** NCT00339456
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08-21
- **Primary completion:** 2008-02-01
- **Final completion:** 2008-02-01
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00339456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00339456, "Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00339456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*